Bernstein Maintains Outperform on Abbott Laboratories, Raises Price Target to $138

Benzinga · 10/17 16:46
Bernstein analyst Lee Hambright maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $133 to $138.